Name: NSRX Balance Sheet - Nasus Pharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

NSRX - Nasus Pharma Ltd.

USD | NYSE | Healthcare

NSRX Balance Sheet - Nasus Pharma Assets & Debt | Ledgeburg

(in millions of USD)	Q4 FY 25	Q2 FY 25	Q4 FY 24	Q2 FY 24	Q4 FY 23	Q4 FY 22
Cash And Short Term Investments
Cash And Equivalents	1.2	0.2	0.3	0.9	-	-
Restricted Cash	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-
Cash And Short Term Investments	1.2	0.2	0.3	0.9	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-
Prepaid Expenses	0.5	0.1	0.1	-	-	-
Other Current Assets
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-
Current Liabilities
Accounts Payable	0.8	0.7	0.7	-	-	-
Short Term Debt	-	-	-	-	-	-
Deferred Revenue Current
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.1	-	-	-	-	-
Common Equity
Common Stock	-	0.0	0.0	-	-	-
Additional Paid In Capital	21.3	9.6	9.4	-	-	-
Retained Earnings
Supplementary Data
Total Debt	-	-	-	-	-	-
Net debt	-	-	-	-	-	-
Working Capital

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022
Cash And Short Term Investments
Cash And Equivalents	1.2	0.3	0.2	-
Restricted Cash	-	-	-	-
Short Term Investments	-	-	-	-
Cash And Short Term Investments	1.2	0.3	0.2	-
Receivables
Accounts Receivable	-	-	-	-
Current Assets
Inventory	-	-	-	-
Prepaid Expenses	0.5	0.1	-	-
Other Current Assets	0.2	0.0	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-
Accumulated Depreciation	-	-	-	-
Property,Plant & Equipment Net	0.0	-	-
Current Liabilities
Accounts Payable	0.8	0.7	-	-
Short Term Debt	-	-	-	-
Deferred Revenue Current	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-
Operating Lease Liabilities Non-Current	0.1	-	-	-
Deferred Revenue Non-Current	-	-	-
Common Equity
Common Stock	-	0.0	-	-
Additional Paid In Capital	21.3	9.4	-	-
Retained Earnings	(18.5)	(12.7)	-	-
Supplementary Data
Total Debt	-	-	-	-
Net debt	-	-	-	-
Working Capital	2.7	(3.5)	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)